RecallDepth
Class III Terminated

BuPROPion Hydrochloride Extended-release Tablets, USP (SR), 100 mg, packaged in a) 60-count bottles (NDC 59746-315-60) and b) 100-count bottles (NDC 59746-315-01), Rx only, Manufactured by: Julibant Life Sciences Ltd., Roorkee-247661, India; Marketed by: Jubilant Cadista Pharmaceuticals Inc., Salisbury, MD 21801, USA.

Company
Jubilant Cadista Pharmaceuticals, Inc.
Recall Initiated
April 8, 2016
Posted
April 19, 2017
Recall Number
D-0669-2017
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
20,882 bottles
Firm Location
Salisbury, MD, United States

Reason for Recall

Failed Impurities/Degradation Specifications: high out of specification results for one of the known degradation products, m-chlorobenzoic acid.

Distribution

Nationwide in the USA

Lot / Code Info

Lot #s: a) BU15001B, BU15003D, Exp 12/16; b) BU15002A, Exp 12/16

More recalls by Jubilant Cadista Pharmaceuticals, Inc.

View all recalls by this company →

Other recent Class III Drug recalls